1. Kaku, Y., Okumura, K., Padilla-Blanco, M., Kosugi, Y., Uriu, K., Hinay, Jr. A.A., Chen, L., Plianchaisuk, A., Kobiyama, K., Ishii K.J., 2023. The Genotype to Phenotype Japan (G2P-Japan) Consortium, Zahradnik J, Ito J, Sato K, Virological characteristics of the SARS-CoV-2 JN.1 variant, bioRxiv [preprint] December 9, 2023. doi: 10.1101/2023.12.08.570782.
2. WHO (2023), https://www.who.int/docs/default-source/coronaviruse/18122023_jn.1_ire_clean.pdf?sfvrsn=6103754a_3 (accessed on 24-12-23).
3. SARS-CoV-2 Variants BA.2.86 and EG.5.1 Alongside Scrub Typhus and Nipah in India During the Ongoing Cricket World Cup 2023: Threat Perceptions and Countermeasures;Mohapatra;Cureus,2023
4. Analyzing the emerging patterns of SARS-CoV-2 Omicron subvariants for the development of next-gen vaccine: An observational study;Mohapatra;Health Sci. Rep.,2023
5. Fast evolution of SARSCoV-2 BA.2·86 to JN.1 under heavy immune pressure;Yang;Lancet Infect Dis,2023